Global sciatica treatment market is expected to reach USD XX Million by 2026, at a CAGR of XX% from 2019 to 2026. Increase in safety and success of drug treatment, increasing geriatrics cases and screenings, and rising excruciating pain among peoples are the major trends for the demand of the market.

Market Overview:

Sciatica occurs when the sciatic nerve is compressed, or pinched. This can be the result of a herniated or bulging disc, a bone spurs, or one of several other conditions. Sciatica pain usually starts from the lower back portion of the body to backwards of the thigh. The common cause of the sciatica is due to direct pressing of a lumbar disc herniation on the nerve. The use of drugs prescribed by the doctors helps to get relief from the pain.


Report Description:

  • The base year for the study has been considered 2018, historic year 2016 and 2017, the forecast period considered is from 2019 to 2026. The global sciatica treatment market is analysed on the basis of  Value (USD Million)
  • The study delivers a comprehensive analysis of global sciatica treatment market by treatment type, end user and regions.
  • The report offers in-depth analysis of driving factors, opportunities, restraints, and challenges for gaining the key insight of the market. The report emphasizes on all the key trends that play a vital role in the enlargement of the market from 2019 to 2026.
  • Porter’s Five Forces model is used in order to recognize the competitive scenario in the global sciatica treatment market. This report incorporates the industry analysis which is focused on providing an extensive view of the sciatica treatment market.
  • The study also includes attractiveness analysis of treatment type, end user and regions which are benchmarked based on their market size, growth rate and attractiveness in terms of present and future opportunity for understanding the future growth of the market.
  • The report provides company profile of the key players operating in the sciatica treatment market and a comparative analysis based on their business overviews, product offering, segment market share, regional presence, business strategies, innovations, mergers & acquisitions, recent developments, joint venture, collaborations, partnerships, SWOT analysis, and key financial information.
  • The market estimates have been evaluated by considering the effect of different political, economic, social, technological and legal factors which are based on our extensive secondary research, primary research, and in-house databases.

Market Dynamics:


  • Increase in safety and success of drug treatment
  • Increasing geriatrics cases and screenings
  • Rising excruciating pain among peoples


  • High cost of treatment
  • Several difficulties in the sciatic surgery


  • Lack of awareness about the disease in the underdeveloped countries


Regional Segmentation Analysis:

The market is analysed on the basis of five regions namely North America, Europe, Asia Pacific, South America, and Middle East and Africa. North America region dominated theglobal sciatica treatment market with highest market sharein 2018.High expenditure on the healthcare especially of the U.S. and Canada, presence of major players, awareness about the diseases, and rapid technological advancements are some of the factors that led to the growth of sciatica treatment market in the North America region.

Competitive Analysis:

The major players of market include are Endo Pharmaceuticals, AstraZeneca, Novartis AG, Teva Pharmaceutical Industries, Neurotech, Nidd Valley Medical, Omega Laser Systems Ltd., Omron Healthcare, Inc., Sanofi, Johnson & Johnson Services, Inc. and among others.  The Endo Pharmaceuticals, AstraZeneca, Novartis AG, and Teva Pharmaceutical Industries are the top leading players of the market.

Customization of the Report:This report can be customized to meet the client’s requirements. Please connect with our sales team (, who will ensure that you get a report that suits your needs.